Funding Announcements

"We have successfully brought our platform to market, providing the technology layer that brings institutional capital to the digital-assets ecosystem. We are grateful to our team of incredibly hard-working and dedicated engineers and to our strategic partners for their immense support."

"In one case, a machine learning engineer used Tenyks to identify the root causes of 80% of their algorithm’s failures. These findings helped them deliver higher quality results to their customers because of the significantly improved system performance. Moreover, future new deployments can be onboarded in half the time because the engineers can now focus their efforts on alleviating the key bottlenecks,"

"Music isn’t just a luxury, it’s an essential part of life. Whether for sleep, mental wellbeing, exercise, or a much-needed adrenalin rush, music is there to soundtrack our lives. LifeScore wants to bring the composer into the action, using Augmented Intelligence to surprise and delight, rendering music reactive and dynamic in real-time. We are thrilled to have found such supportive partners in this investment round, and believe that this will enable us to bring an entirely new music platform to fruition whilst creating many opportunities for musicians."

"As we continue to focus on growing an investment portfolio of like-minded purpose-driven businesses, we were particularly impressed with WeAre8 and its founder Sue Fennessy. The WeAre8 technology presents a compelling and ethical alternative social digital platform for brands to communicate with consumers. We’re really excited to support WeAre8 and hope the campaign launch across our powerful marketing platform will resonate with our core young viewers who care passionately about environmental and societal issues, and drive mass adoption in the UK."

"This major fundraise is a substantial validation of both our team and our world-leading technology. We are fortunate to have the support from new and current investors who have recognised the importance of the microbiome's therapeutic potential and Microbiotica's unique capabilities."